The novel PDE10A inhibitor CPL'36 offers a new mechanism of action and is both safe and effective for acute exacerbations of schizophrenia, new research suggests.

Under a Republican-led budget bill, US doctors and dentists would no longer be able to count residency years toward the ...

These students say maintaining a simple hobby isn’t a distraction — it’s a mental health weapon that helps them maintain ...

Adding Blenrep to standard therapy prolonged progression-free survival in patients with relapsed or refractory multiple ...

Newly recognized issues, including extreme fatigue with excessive weight reduction, bone loss, and abdominal pain, point to ...

Experts call for stronger regulation of digital food marketing to counter the increasing risk for obesity and teens’ ...

Glyceraldehyde links chronic stress to depression by driving inflammation and telomere shortening, offering a potential ...

The new infusion for maple syrup urine disease is for patients who cannot have an oral or enteral branched-chain amino ...

The two active substances are antivirals that inhibit HIV reverse transcriptase through incorporation into the viral DNA, ...

AI may support cognitive behavioral therapy by offering structure, but it lacks the all-important human touch, a new pilot ...

The autologous immunotherapy consists of the patient’s own T cells engineered to express a chimeric antigen receptor that ...

The active substance of Ezmekly, mirdametinib, is a selective, non-competitive mitogen-activated protein kinase 1 and 2 (MEK ...